Beyond chemobrain: A stepwise approach to identifying cognitive impairment in non-CNS cancer survivors.

Authors

Martina Pulze, Mattia Losa, Silvia Buonopane, Paolo Alì, Stefano Caneva, Matteo Pardini

Published in

Tumori. Pages 3008916261489141. Oct 07, 2026. Epub Oct 07, 2026.

Abstract

Cancer-related cognitive impairment (CRCI) is common in patients with non-central nervous system malignancies, but its identification remains difficult because symptoms are heterogeneous, may predate treatment, and are not captured by a single measure. This narrative review synthesizes evidence on epidemiology, clinical phenotype, risk factors, neuropsychological assessment, neuroimaging, and practical pathways for identifying CRCI in oncology care. Emerging literature highlights subjective-objective discordance and self-awareness as clinically relevant dimensions. Prevalence varies by timing and method, with higher estimates from self-report than from screening tools or formal batteries. Identification is more reliable when assessment combines patient-reported outcomes (PRO), brief objective screening, and focused neuropsychological testing within baseline vulnerability and concurrent symptom burden. Older age, lower cognitive reserve, pretreatment cognitive impairment, systemic illness, fatigue, insomnia, mood symptoms, pain, and medication effects are major modifiers. In clinical settings, neuroimaging is useful primarily for differential diagnosis: conventional brain MRI excludes competing neurologic disorders, while volumetric MRI, diffusion imaging, resting-state functional MRI, and [18F]FDG-PET currently provide group-level evidence rather than individual diagnostic signatures. At present, CRCI is best identified through a stepwise clinical strategy integrating PRO evaluation, objective testing, risk profiling, and selective imaging, considering individual patient modifiers rather than a single diagnostic test.

PMID:
42844858
Bibliographic data and abstract were imported from PubMed on 08 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.